|
|
| | α-Keto Isovaleric Acid Sodium Salt Dimethyl-13C2 Basic information |
| | α-Keto Isovaleric Acid Sodium Salt Dimethyl-13C2 Chemical Properties |
| Melting point | 227-230°C (lit.) | | form | solid | | color | White to off-white | | InChI | 1S/C5H8O3.Na/c1-3(2)4(6)5(7)8;/h3H,1-2H3,(H,7,8);/q;+1/p-1/i1+1,2+1; | | InChIKey | WIQBZDCJCRFGKA-AWQJXPNKSA-M | | SMILES | [Na+].[13CH3]C([13CH3])C(=O)C([O-])=O | | CAS Number Unlabeled | 3715-29-5 |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids |
| | α-Keto Isovaleric Acid Sodium Salt Dimethyl-13C2 Usage And Synthesis |
| Uses | 3-Methyl-2-oxobutanoic acid-13C2 is the 13C labeled Sodium 3-methyl-2-oxobutanoate[1]. Sodium 3-methyl-2-oxobutanoate is a precursor of pantothenic acid in Escherichia coli[2][3][4]. | | References | [1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. DOI:10.1177/1060028018797110
[2] MAAS WK, et al. alpha-Ketoisovaleric acid, a precursor of pantothenic acid in Escherichia coli. J Bacteriol. 1953 Apr;65(4):388-93. DOI:10.1128/jb.65.4.388-393.1953
[3] Schauder P, et al. Oral administration of alpha-ketoisovaleric acid or valine in humans: blood kinetics and biochemical effects. J Lab Clin Med. 1984 Apr103(4):597-605. PMID:6366097
[4] Coitinho AS, et al. Pharmacological evidence that alpha-ketoisovaleric acid induces convulsions through GABAergic and glutamatergic mechanisms in rats. Brain Res. 2001 Mar 9894(1):68-73. DOI:10.1016/s0006-8993(00)03321-7 |
| | α-Keto Isovaleric Acid Sodium Salt Dimethyl-13C2 Preparation Products And Raw materials |
|